本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

2.38
-0.0600-2.46%
盘后2.390.0100+0.42%19:58 EDT
成交量:12.60万
成交额:30.44万
市值:567.86万
市盈率:-0.01
高:2.50
开:2.45
低:2.36
收:2.44
数据加载中...
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/06/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/15

重要事件披露

8-K - Current report
2021/06/15

重要事件披露

8-K - Current report
2021/06/15

重要事件披露

8-K - Current report
2021/05/26

重要事件披露

8-K - Current report
2021/05/21

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/21

重要事件披露

8-K - Current report
2021/05/19

重要事件披露

8-K - Current report
2021/05/18

重要事件披露

8-K - Current report
2021/05/18

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/18

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/17

重要事件披露

8-K - Current report
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/13

重要事件披露

8-K - Current report